IL113940A - Synthetic peptides which are elastase inhibitors and pharmaceutical compositions for the treatment of neutrophil associated inflammatory disease containing said inhibitors - Google Patents
Synthetic peptides which are elastase inhibitors and pharmaceutical compositions for the treatment of neutrophil associated inflammatory disease containing said inhibitorsInfo
- Publication number
- IL113940A IL113940A IL11394095A IL11394095A IL113940A IL 113940 A IL113940 A IL 113940A IL 11394095 A IL11394095 A IL 11394095A IL 11394095 A IL11394095 A IL 11394095A IL 113940 A IL113940 A IL 113940A
- Authority
- IL
- Israel
- Prior art keywords
- inhibitors
- treatment
- inflammatory disease
- synthetic peptides
- elastase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25279994A | 1994-06-02 | 1994-06-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL113940A0 IL113940A0 (en) | 1995-08-31 |
IL113940A true IL113940A (en) | 1999-12-31 |
Family
ID=22957608
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11394095A IL113940A (en) | 1994-06-02 | 1995-05-31 | Synthetic peptides which are elastase inhibitors and pharmaceutical compositions for the treatment of neutrophil associated inflammatory disease containing said inhibitors |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0804465B1 (fr) |
JP (1) | JP3623799B2 (fr) |
KR (1) | KR100347285B1 (fr) |
CN (1) | CN1149877A (fr) |
AT (1) | ATE246708T1 (fr) |
AU (1) | AU689589B2 (fr) |
CA (1) | CA2189527C (fr) |
DE (1) | DE69531459T2 (fr) |
DK (1) | DK0804465T3 (fr) |
ES (1) | ES2199992T3 (fr) |
FI (1) | FI964781A (fr) |
HU (1) | HU221197B1 (fr) |
IL (1) | IL113940A (fr) |
NO (1) | NO965097L (fr) |
NZ (1) | NZ285565A (fr) |
PT (1) | PT804465E (fr) |
SI (1) | SI0804465T1 (fr) |
TW (1) | TW403762B (fr) |
WO (1) | WO1995033763A1 (fr) |
ZA (1) | ZA954430B (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU221310B1 (en) * | 1994-06-02 | 2002-09-28 | Merrell Pharma Inc | Acylated enol di and tripeptide derivatives, their use and pharmaceutical compositions comprising thereof |
CA2189526C (fr) * | 1994-06-02 | 2001-02-27 | William A. Metz, Jr. | Inhibiteurs d'elastase au perfluoroalkyle cetone et procedes de production associes |
US6172044B1 (en) | 1995-12-01 | 2001-01-09 | Aventis Pharmaceuticals Inc. | Acylated enol derivative of α-ketoesters and α-ketoamides |
US5948886A (en) * | 1996-11-20 | 1999-09-07 | Hoechst Marion Roussel, Inc. | Acylated enol derivatives of α-ketoesters and α-ketoamides |
US6767991B1 (en) | 1997-08-11 | 2004-07-27 | Boehringer Ingelheim (Canada) Ltd. | Hepatitis C inhibitor peptides |
BRPI0410456B8 (pt) | 2003-05-21 | 2021-05-25 | Boehringer Ingelheim Int | compostos inibidores de hepatite c, composição farmacêutica, uso dos mesmos, bem como artigo de fabricação |
CA2573346C (fr) | 2004-07-20 | 2011-09-20 | Boehringer Ingelheim International Gmbh | Analogues peptidiques inhibiteurs de l'hepatite c |
UY29016A1 (es) | 2004-07-20 | 2006-02-24 | Boehringer Ingelheim Int | Analogos de dipeptidos inhibidores de la hepatitis c |
RU2419626C2 (ru) | 2006-05-23 | 2011-05-27 | Айрм Ллк | Соединения и композиции в качестве ингибиторов протеазы, активирующей каналы |
EA016327B1 (ru) * | 2007-02-09 | 2012-04-30 | Айрм Ллк | Соединения и композиции в качестве ингибиторов протеазы, активирующей каналы |
EP4031138A1 (fr) | 2019-09-17 | 2022-07-27 | Mereo Biopharma 4 Limited | Alvélestat destiné à être utilisé dans le traitement du rejet de greffe, du syndrome de bronchiolite oblitérante et de la maladie du greffon contre l'hôte |
MX2022012942A (es) | 2020-04-16 | 2023-01-11 | Mereo Biopharma 4 Ltd | Metodos que involucran el inhibidor de la elastasa de neutrofilo alvelestat para el tratamiento de enfermedades respiratorias mediadas por deficiencia de alfa-1 antitripsina. |
IL312002A (en) | 2021-10-20 | 2024-06-01 | Mereo Biopharma 4 Ltd | Neutrophil elastase inhibitors for use in the treatment of fibrosis |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8600263D0 (en) * | 1985-01-22 | 1986-02-12 | Ici America Inc | Peptide derivatives |
EP0204571B1 (fr) * | 1985-06-07 | 1992-01-22 | Ici Americas Inc. | Dérivés difluoro choisis |
ZA905737B (en) * | 1989-07-26 | 1991-05-29 | Merrell Dow Pharma | Novel peptidase inhibitors |
EP0564561A4 (en) * | 1990-12-28 | 1994-08-10 | Georgia Tech Res Inst | Peptides ketoamides, ketoacids, and ketoesters |
ZA926185B (en) * | 1991-08-22 | 1993-03-01 | Merrell Dow Pharma | Novel orally-active elastase inhibitors. |
-
1995
- 1995-05-05 NZ NZ285565A patent/NZ285565A/en unknown
- 1995-05-05 HU HU9603312A patent/HU221197B1/hu not_active IP Right Cessation
- 1995-05-05 SI SI9530682T patent/SI0804465T1/xx unknown
- 1995-05-05 CA CA002189527A patent/CA2189527C/fr not_active Expired - Fee Related
- 1995-05-05 CN CN95193386A patent/CN1149877A/zh active Pending
- 1995-05-05 ES ES95918993T patent/ES2199992T3/es not_active Expired - Lifetime
- 1995-05-05 WO PCT/US1995/005618 patent/WO1995033763A1/fr active IP Right Grant
- 1995-05-05 KR KR1019960706818A patent/KR100347285B1/ko not_active IP Right Cessation
- 1995-05-05 AU AU24709/95A patent/AU689589B2/en not_active Ceased
- 1995-05-05 PT PT95918993T patent/PT804465E/pt unknown
- 1995-05-05 AT AT95918993T patent/ATE246708T1/de not_active IP Right Cessation
- 1995-05-05 EP EP95918993A patent/EP0804465B1/fr not_active Expired - Lifetime
- 1995-05-05 DK DK95918993T patent/DK0804465T3/da active
- 1995-05-05 DE DE69531459T patent/DE69531459T2/de not_active Expired - Lifetime
- 1995-05-05 JP JP50087196A patent/JP3623799B2/ja not_active Expired - Fee Related
- 1995-05-30 ZA ZA954430A patent/ZA954430B/xx unknown
- 1995-05-31 TW TW084105515A patent/TW403762B/zh not_active IP Right Cessation
- 1995-05-31 IL IL11394095A patent/IL113940A/xx not_active IP Right Cessation
-
1996
- 1996-11-29 FI FI964781A patent/FI964781A/fi unknown
- 1996-11-29 NO NO965097A patent/NO965097L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0804465B1 (fr) | 2003-08-06 |
AU689589B2 (en) | 1998-04-02 |
DE69531459D1 (de) | 2003-09-11 |
CA2189527A1 (fr) | 1995-12-14 |
AU2470995A (en) | 1996-01-04 |
NO965097L (no) | 1997-01-31 |
FI964781A (fi) | 1997-01-29 |
NZ285565A (en) | 1998-08-26 |
WO1995033763A1 (fr) | 1995-12-14 |
EP0804465A1 (fr) | 1997-11-05 |
FI964781A0 (fi) | 1996-11-29 |
KR100347285B1 (ko) | 2003-01-15 |
DE69531459T2 (de) | 2004-06-24 |
ATE246708T1 (de) | 2003-08-15 |
CN1149877A (zh) | 1997-05-14 |
JPH10500992A (ja) | 1998-01-27 |
SI0804465T1 (en) | 2003-12-31 |
HU221197B1 (en) | 2002-08-28 |
DK0804465T3 (da) | 2003-11-24 |
HU9603312D0 (en) | 1997-01-28 |
PT804465E (pt) | 2003-12-31 |
CA2189527C (fr) | 2000-12-19 |
MX9606030A (es) | 1998-05-31 |
TW403762B (en) | 2000-09-01 |
JP3623799B2 (ja) | 2005-02-23 |
ZA954430B (en) | 1996-02-13 |
ES2199992T3 (es) | 2004-03-01 |
HUT76926A (hu) | 1998-01-28 |
IL113940A0 (en) | 1995-08-31 |
NO965097D0 (no) | 1996-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG101841A (en) | Cellular adhesion inhibitors | |
BG101118A (en) | Therapeutical compounds | |
BG103417A (en) | Condensed pyrimidine bicyclic derivatives | |
IL127965A0 (en) | Pentafluorobenzenesulfonamide derivatives analogs thereof and pharmaceutical compositions containing the same | |
BR9713400A (pt) | Processos e compostos para inibir liberação de peptìdeo beta-amilóide e/ou sua sìntese. | |
MX9706069A (es) | Nuevos inhibidores de la trombina. | |
LU91145I9 (fr) | ||
IL125282A (en) | Substituted imidazole compounds, process for their preparation, pharmaceutical compositions containing them and use thereof in the preparation of medicaments for treating cytokine mediated diseases | |
IL123002A0 (en) | 1-Phenyl-2- phenylacetoxy- ethanone derivatives | |
UA49869C2 (uk) | Нафтил-заміщені похідні бензимідазолу, фармацевтична композиція, спосіб лікування (варіанти) та спосіб інгібування людського фактора | |
IL102858A0 (en) | Novel orally-active elastase inhibitors | |
IL113941A (en) | Perfluoroalkyl ketone inhibitors of elastase processes for making the same and pharmaceutical compositions containing them | |
AP9701041A0 (en) | Pyridylpyrrole compounds. | |
DE69713151D1 (de) | Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung | |
IL113940A (en) | Synthetic peptides which are elastase inhibitors and pharmaceutical compositions for the treatment of neutrophil associated inflammatory disease containing said inhibitors | |
TR199802537T2 (xx) | Peptit t�revleri. | |
FI972308A (fi) | 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi | |
NZ330944A (en) | Peptide derivatives | |
AP2000001761A0 (en) | Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase. | |
AP2000001760A0 (en) | Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase. | |
DE69726743D1 (de) | Peptid analoge, die einen siebengliedrigen lactamring enthalten | |
PL336897A1 (en) | Novel salts of bpc peptides, pharmaceutic compositions conatining them and method of obtaining such salts | |
GEP20032975B (en) | Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition | |
FR2786767B1 (fr) | Nouveaux derives de 3-alkoxybenzylamines et leur utilisation a titre de medicaments pour le traitement de la schizophrenie | |
MX9704796A (es) | Peptidos novedosos, su preparacion y uso. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |